The endocrinology of obesity.
Numerous endocrine alterations are associated with obesity (Table 1). The majority of the alterations are secondary to obesity and must be considered simply associated and potentially in the pathogenesis of the complications of obesity. The discovery of new endocrine peptides such as leptin that signal body fat content will increase our understanding of the regulation of body fat content. As a result, therapies will most certainly be developed that are directly targeted at the alterations in endocrine function.
Smith
S R
SR
Inpatient Metabolic Unit, Pennington Biomedical Research Center, Louisiana State University, Baton Rouge, USA.
D000273:Adipose Tissue / Q000502:physiology; D000818:Animals; D004702:Endocrine Glands / Q000502:physiology*; D005260:Female; D006801:Humans; D007328:Insulin / Q000502:physiology; D007515:Islets of Langerhans / Q000502:physiology; D008297:Male; D009765:Obesity / Q000097:blood / Q000503:physiopathology*; D010053:Ovary / Q000502:physiology; D010908:Pituitary Hormones, Anterior / Q000502:physiology; D010913:Pituitary-Adrenal System / Q000502:physiology; D013737:Testis / Q000502:physiology
D007328:Insulin; D010908:Pituitary Hormones, Anterior